DE4244418A1 - Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. - Google Patents
Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc.Info
- Publication number
- DE4244418A1 DE4244418A1 DE19924244418 DE4244418A DE4244418A1 DE 4244418 A1 DE4244418 A1 DE 4244418A1 DE 19924244418 DE19924244418 DE 19924244418 DE 4244418 A DE4244418 A DE 4244418A DE 4244418 A1 DE4244418 A1 DE 4244418A1
- Authority
- DE
- Germany
- Prior art keywords
- peptides
- preparation
- collagen
- mol
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
Description
Die Erfindung betrifft Peptid-Präparate und Verfahren zu deren Herstellung.The invention relates to peptide preparations and methods for their Manufacturing.
Bei der Suche nach wirksamen Inhaltsstoffen aus tierischen Geweben für die Anwendung in der Medizin, Biotechnologie und Kosmetik wurden in den vergangenen Jahrzehnten eine große Zahl von Substanzen und Substanzgemischen extrahiert, vollständig oder partiell charakterisiert und erfolgreich angewandt. Stellvertretend seien nur einige wenige Substanzen erwähnt, wie Epidermal Growth Factor, Kollagen Typ I und Typ III und Hyaluronsäure (British Medical Bulletin, vol. 45, no. 2, 1989, "Growth Factors", ed. M. D. Waterfield, Churchill Livingstone, Edinburgh; Collagen in Health and Disease, eds. J. B. Weiss and M. I. V. Jayson, Churchill Livingstone, Edinburgh, 1982; Methods in Enzymology, vol. 82, 1982, "Structural and Contractile Proteins, Part A", eds. L. W. Cunningham and D. W. Frederiksen, vol. 144, 1987, "Structural and Contractile Proteins, Part D", ed. L. W. Cunningham, Academic Press, Inc., Orlando).When looking for effective ingredients from animal tissues for use in medicine, biotechnology and cosmetics a large number of substances and substance mixtures in the past decades extracted, fully or partially characterized and successful applied. Only a few substances are representative mentions such as epidermal growth factor, collagen type I and type III and Hyaluronic Acid (British Medical Bulletin, vol. 45, no. 2, 1989, "Growth Factors, ed. M.D. Waterfield, Churchill Livingstone, Edinburgh; Collagen in Health and Disease, eds. J. B. Weiss and M. I. V. Jayson, Churchill Livingstone, Edinburgh, 1982; Methods in Enzymology, vol. 82, 1982, "Structural and Contractile Proteins, Part A", eds. L. W. Cunningham and D. W. Frederiksen, vol. 144, 1987, "Structural and Contractile Proteins, Part D ", ed. L.W. Cunningham, Academic Press, Inc., Orlando).
Viele der bisher gefundenen Wirkstoffe sind sehr komplexe Moleküle, wie Proteine, Polypeptide oder Mucopolysaccharide, die aus kleinen Bausteinen von den Gewebezellen synthetisiert werden. Das Ziel bisheriger Bemühungen war im wesentlichen die Extraktion, mit eventuell anschließender chemisch-physikalischer Modifikation dieser komplexen Moleküle, um sie dann sinnvoll anzuwenden.Many of the active ingredients found so far are very complex molecules, such as Proteins, polypeptides or mucopolysaccharides made up of small building blocks are synthesized by the tissue cells. The goal so far Efforts were essentially the extraction, with any subsequent one chemical-physical modification of these complex molecules, in order to then use them sensibly.
Durch enzymatischen oder chemisch-physikalischen Abbau verlieren diese Makromoleküle jedoch in der Regel ihre Wirkung oder erfahren Wirkungseinbußen oder Wirkungsverschiebungen. Wenn zum Beispiel Kollagen zu Gelatine abgebaut wird, verringert sich das für die Kosmetik wichtige Wasserbindevermögen [Parfümerie und Kosmetik 65 (7), 1984, 391 bis 401, Alexander Berg: "Einsatz von Proteinen in der Kosmetik"; RAK - Riechstoffe, Aromen, Kosmetica (7), 1977, R. Riemschneider, W. H. Chik: "Über das Wasserbindevermögen löslicher Kollagene"]. Beim weiteren Abbau von Gelatine zu Gelatinehydrolysat werden Peptide mit einem Molekulargewicht von 500 bis 30 000 Dalton freigesetzt, die im Vergleich zur Gelatine ein besseres Aufziehvermögen für Haare besitzen und daher im Bereich der Haarpflege große Bedeutung erlangt haben. Lose through enzymatic or chemical-physical degradation however, these macromolecules usually have their effects or experience Impact or postponement of impact. If, for example, collagen degraded to gelatin, this reduces for cosmetics important water binding capacity [Perfumery and Cosmetics 65 (7), 1984, 391 bis 401, Alexander Berg: "Use of proteins in cosmetics"; RAK - Fragrances, flavors, cosmetics (7), 1977, R. Riemschneider, W. H. Chik: "About the water binding ability of soluble collagens"]. In the further Degradation of gelatin to gelatin hydrolyzate are peptides with a molecular weight released from 500 to 30,000 daltons, which compared to Gelatine has a better ability to draw up hair and therefore in Of hair care have become very important.
Gegenstand der vorliegenden Erfindung ist die Entdeckung, daß die unter definierten Bedingungen gewonnenen Partialhydrolysate, die daraus isolierten Peptide und die Mischungen von Aminosäuren und Peptiden, deren Aminosäuresequenzen mit den Teilabschnitten der Protein-Aminosäuresequenz übereinstimmen, neue Wirkungseigenschaften besitzen, die über die Wirkung der intakten Proteine deutlich hinausgehen.The present invention is the discovery that the Partial hydrolyzates obtained under defined conditions isolated peptides and the mixtures of amino acids and peptides whose Amino acid sequences with the sections of the protein amino acid sequence agree, have new properties of action that are beyond the effect of the intact proteins.
Als Beispiel wird kurz auf Kollagen Typ I hingewiesen.As an example, collagen type I is briefly mentioned.
Kollagene, von denen mindestens 13 unterschiedliche Typen isoliert und charakterisiert wurden, dienen vorwiegend als Strukturproteine im Bindegewebe multizellulärer Organismen. Spezifische Zellen, wie zum Beispiel Fibroblasten in der Dermis, synthetisieren die nadelförmigen Proteinmoleküle, die aus drei miteinander verdrillten, kabelähnlichen Polypeptiden zusammengesetzt sind. Bei Kollagen Typ I besitzen zwei der drei Polypeptide identische Aminosäuresequenzen und werden als alpha-1(I)- Polypeptide bezeichnet (Fig. 4), während das dritte Polypeptid, alpha- 2(I), eine andere Aminosäuresequenz hat (Fig. 5). Jedes Polypeptid enthält etwa 1000 Aminosäuren. Das gesamte Protein hat eine Länge von ca. 0,3 µm und einen Durchmesser von ca. 0,0015 µm.Collagens, of which at least 13 different types have been isolated and characterized, serve primarily as structural proteins in the connective tissue of multicellular organisms. Specific cells, such as fibroblasts in the dermis, synthesize the needle-shaped protein molecules, which are composed of three twisted, cable-like polypeptides. In collagen type I, two of the three polypeptides have identical amino acid sequences and are referred to as alpha-1 (I) polypeptides ( FIG. 4), while the third polypeptide, alpha- 2 (I), has a different amino acid sequence ( FIG. 5) . Each polypeptide contains approximately 1000 amino acids. The entire protein has a length of approx. 0.3 µm and a diameter of approx. 0.0015 µm.
Wegen der filmbildenden Eigenschaften und des großen Wasseraufnahmevermögens wird Kollagen in bedeutenden Mengen in der Kosmetik eingesetzt. Die kosmetische Wirkung von Kollagen war bisher im wesentlichen auf diese Eigenschaften beschränkt, bedingt sowohl durch die chemische Struktur des Kollagens als auch durch die Molekülgröße, die ein Eindringen in die Haut verhindert.Because of the film-forming properties and the large water absorption capacity significant amounts of collagen are used in cosmetics. The cosmetic effect of collagen has so far been essentially limited to these properties, due to both the chemical Structure of the collagen as well as the size of the molecules that penetrate prevented in the skin.
Wenn dagegen ein Partialhydrolysat von Kollagen unter genau definierten Bedingungen hergestellt wird (siehe Herstellung Präparat A) oder ein Gemisch aus Aminosäuren und Peptiden zubereitet wird (Herstellung Präparat B), dessen Aminosäurezusammensetzung der Kollagen- Aminosäure-Analyse annähernd entspricht und dessen Peptide Aminosäuresequenzen haben, die mit bestimmten Kollagen-Aminosäuresequenzen exakt übereinstimmen (Fig. 4 und 5), so weisen diese Präparate neue positive Wirkungen und Eigenschaften auf.If, on the other hand, a partial hydrolyzate of collagen is produced under precisely defined conditions (see preparation preparation A) or a mixture of amino acids and peptides is prepared (preparation preparation B), the amino acid composition of which approximately corresponds to the collagen-amino acid analysis and whose peptides have amino acid sequences that exactly match certain collagen amino acid sequences ( Fig. 4 and 5), these preparations have new positive effects and properties.
Diese Wirkungen sind zum Teil in Tabelle 1 zusammengefaßt. Die wirksamen Präparate werden darin Präparat B und GHL-Peptid (GHL=Glycyl- Histidyl-Lysin=Tripeptidfraktion A) genannt, und sie werden mit den Eigenschaften des nativen Kollagens verglichen. Some of these effects are summarized in Table 1. The active preparations are included in preparation B and GHL peptide (GHL = glycyl Histidyl-lysine = tripeptide fraction A) called, and they are with the Properties of native collagen compared.
Diese Partialhydrolysate, isolierten Peptide und Präparate aus Aminosäuren und Peptiden sind von besonderer BedeutungThese partial hydrolyzates, isolated peptides and preparations from Amino acids and peptides are of particular importance
- 1. für die Biotechnologie, als Zusatz für Zellkultur-Nährlösungen für serumarme oder definierte, serumfreie Zellkultur-Nährmedien (Applikationsbeispiel 1),1. for biotechnology, as an additive for cell culture nutrient solutions for low-serum or defined, serum-free cell culture nutrient media (application example 1),
- 2. für die Medizin, als wundheilungsförderndes Mittel (Applikationsbeispiel 2), zur Immunstimulation und Wirkstoff zur Erhöhung der körpereigenen Erythropoetinbildung, und2. for medicine, as a wound healing agent (application example 2), for immune stimulation and active ingredient for increasing the body's erythropoietin formation, and
- 3. für die Kosmetik, zur Pflege der Haut, als Anti-Aging-Faktor und Radikalfängerkomplex (Applikationsbeispiele 3 bis 5).3. for cosmetics, for skin care, as an anti-aging factor and Radical scavenger complex (application examples 3 to 5).
Die Komponenten der Rezeptur (Tabellen 2 bis 14: Rezepturfraktionen) werden in geeigneter Weise vorgelöst und gemischt. Einzelne Komponenten der Rezeptur, wie zum Beispiel die Tripeptidfraktion A und Tripeptidfraktion B, werden nach der Partialhydrolyse (grundsätzliche Methoden der Herstellung 3 bis 5) mit Hilfe chromatographischer Methoden gereinigt, isoliert, konzentriert und anschließend dem Präparat zugegeben.The components of the recipe (tables 2 to 14: formulation fractions) are pre-dissolved and mixed in a suitable manner. Individual components of the formulation, such as the tripeptide fraction A and tripeptide fraction B, are after partial hydrolysis (basic methods of preparation 3 to 5) using chromatographic Methods cleaned, isolated, concentrated and then the Preparation added.
Komponenten der Rezeptur werden mit gentechnologisch gewonnenen Substanzen und/oder mit Partialhydrolysaten (siehe grundsätzliche Methoden der Herstellung 3 bis 5) gemischt.Components of the recipe are included substances obtained by genetic engineering and / or with partial hydrolyzates (see basic methods of preparation 3 to 5) mixed.
Tierhaut oder Tierlunge, Kollagen, Gelatine oder Elastin werden, wie in Anspruch 2 beschrieben, hydrolysiert, anschließend filtriert, neutralisiert und mit Hilfe zum Beispiel der Umkehrosmose entsalzt. Gegebenenfalls erfolgt eine Behandlung mit 1n-NaOH, eine Stunde bei Zimmertemperatur, mit anschließender Neutralisation und erneuter Entsalzung.Animal skin or animal lung, Collagen, gelatin or elastin are, as described in claim 2, hydrolyzed, then filtered, neutralized and with Help, for example, desalinated reverse osmosis. If applicable treatment with 1n-NaOH, one hour at room temperature, followed by Neutralization and desalination.
Dieses Enzym spaltet die sich wiederholende Gly-X-Y-Gly-X- Y-Gly-X-Y-Gly-Aminosäuresequenz des Kollagens zwischen dem Y und Glycin (X, Y stehen für unterschiedliche Aminosäuren in der Kollagen-Aminosäuresequenz). Tierhaut oder Tierlunge bzw. Kollagen Typ I wird in Tris-HCl- Puffer, pH 7,6, in Anwesenheit von CaCl₂ 90 Minuten bei 37°C mit Kollagenase behandelt und die Lösung anschließend 24 Stunden bei +4°C dialysiert, konserviert und sterilfiltriert.This enzyme cleaves the repeating Gly-X-Y-Gly-X- Y-Gly-X-Y-Gly amino acid sequence of the collagen between the Y and glycine (X, Y stand for different amino acids in the collagen amino acid sequence). Animal skin or animal lung or collagen type I is in Tris-HCl Buffer, pH 7.6, in the presence of CaCl₂ for 90 minutes at 37 ° C with collagenase treated and the solution then dialyzed at + 4 ° C for 24 hours, preserved and sterile filtered.
Tierepidermis wird im Citrat-HCl-Puffer, pH 1,5, 24 Stunden bei Zimmertemperatur mit Pepsin behandelt (Verhältnis Pepsin zu Substrat 1 : 10), dialysiert, 24 Stunden bei pH 10,5 bei Zimmertemperatur gelagert, 1 Stunde mit 1n-NaOH bei Zimmertemperatur behandelt, neutralisiert, entsalzt und sterilfiltriert.Animal epidermis is in the citrate-HCl buffer, pH 1.5, 24 hours at room temperature with Treated pepsin (ratio pepsin to substrate 1:10), dialyzed, 24 hours stored at pH 10.5 at room temperature, 1 hour with 1N NaOH Treated, neutralized, desalted and sterile filtered at room temperature.
Geeignete Mikroorganismen werden nach bekannten Techniken so behandelt, daß sie veränderte Kollagen-, Elastin- und Hautkeratinmoleküle synthetisieren, die eine größere Anzahl wirksamer Peptidsequenzen enthalten. Diese veränderten Proteine erhöhen die Ausbeute bei der Gewinnung wirksamer Peptidsequenzen durch partielle Hydrolyse. Suitable microorganisms are treated according to known techniques so that they changed Synthesize collagen, elastin and skin keratin molecules that contain a larger number of effective peptide sequences. These changed Proteins increase the yield in the production of effective peptide sequences by partial hydrolysis.
Das natürliche Präparat entspricht den Beschreibungen gemäß Anspruch 2 und den grundsätzlichen Methoden der Herstellung 3 bis 5.The natural preparation corresponds to the Descriptions according to claim 2 and the basic methods of Manufacturing 3 to 5.
Die in den Tabellen 2 bis 5 genannten Aminosäuren stehen vorwiegend für Aminosäuren pflanzlichen Ursprungs. The amino acids mentioned in Tables 2 to 5 mainly stand for Amino acids of vegetable origin.
Die Buchstaben X, Y stehen für Aminosäuren beliebiger Art und Menge von jeweils 0 bis maximal 50.The letters X, Y stand for amino acids of any kind and amount of 0 to a maximum of 50 each.
Die Peptide in den Tabellen 6 bis 8 können als natürliche isolierte Peptide oder/und als synthetisch hergetellte Peptide eingesetzt werden. The peptides in Tables 6 to 8 can be isolated as natural peptides or / and used as synthetically produced peptides.
5% fötales Kälberserum.
Applikationsbeispiel 2
Medizin
Zur Förderung der Wundheilung werden ca. 2 bis 5% der beschriebenen
Präparate oder mindestens 50 bis 200 mg Gly-His-Lys/kg in medizinische
Salben, Cremes, Lotionen, Tinkturen, Wundheilungssprays eingearbeitet
oder Wundabdeckungen damit imprägniert.
Applikationsbeispiele 3 bis 5
Kosmetik
Mindestens drei Wirkeigenschaften der in dieser Erfindung beschriebenen
Präparate weisen auf eine erfolgreiche Anwendung bei der Pflege der Haut:
Die Steigerung der Stoffwechselaktivität, die Radikalfängerwirkung und
die Stimulierung der Kollagensynthese von Fibroblasten.
Die kosmetischen Präparate zur Pflege der Haut: Feuchtigkeits- und Tagescremes
für trockene Haut, Nachtcremes, Sonnenschutzpräparate, After-Sun-
Lotionen, Anti-Falten-Cremes, Hautschutzcremes und After-Shave-Lotionen
sollten eine Mindestkonzentration von 2 bis 5% der in dieser Erfindung beschriebenen
Präparate enthalten.
Applikationsbeispiel 3
Feuchtigkeitscreme
5% fetal calf serum. Application example 2 Medicine To promote wound healing, approx. 2 to 5% of the described preparations or at least 50 to 200 mg Gly-His-Lys / kg are incorporated into medical ointments, creams, lotions, tinctures, wound healing sprays or impregnated with wound coverings. Application Examples 3 to 5 Cosmetics At least three active properties of the preparations described in this invention indicate successful use in skin care: the increase in metabolic activity, the radical scavenger effect and the stimulation of collagen synthesis by fibroblasts. The cosmetic preparations for skin care: moisturizing and day creams for dry skin, night creams, sunscreen preparations, after-sun lotions, anti-wrinkle creams, skin protection creams and after-shave lotions should have a minimum concentration of 2 to 5% in this Preparations described invention contain. Application example 3 moisturizer
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19924244418 DE4244418A1 (en) | 1991-12-30 | 1992-12-30 | Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4143178 | 1991-12-30 | ||
DE19924244418 DE4244418A1 (en) | 1991-12-30 | 1992-12-30 | Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. |
Publications (1)
Publication Number | Publication Date |
---|---|
DE4244418A1 true DE4244418A1 (en) | 1993-07-01 |
Family
ID=25910591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19924244418 Withdrawn DE4244418A1 (en) | 1991-12-30 | 1992-12-30 | Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE4244418A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0781779A3 (en) * | 1995-12-27 | 1999-04-07 | Miyagi Kagaku Kogyo Kabushiki Kaisha | Nonantigenic stabilizer and physiologically active substance |
EP1054677A1 (en) * | 1998-11-19 | 2000-11-29 | Mrs, Llc | Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
WO2001043701A2 (en) * | 1999-12-17 | 2001-06-21 | Sederma | Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide |
FR2827170A1 (en) * | 2001-07-13 | 2003-01-17 | Soc Extraction Principes Actif | Promoting cellular adhesion, especially for treating skin aging symptoms and improving skin appearance, using peptide having monomeric, dimeric or trimeric glycyl-prolyl-glutaminyl sequence |
EP1297821A1 (en) * | 2001-10-01 | 2003-04-02 | Hive of Beauty (Europe) BVBA | Skin treatment compositions |
WO2004014413A1 (en) * | 2002-07-31 | 2004-02-19 | Procyte Corporation | Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
WO2004087191A1 (en) * | 2003-04-01 | 2004-10-14 | Lipotec, S.A. | Composition for the prevention and treatment of cellulitis |
WO2004087192A1 (en) * | 2003-04-01 | 2004-10-14 | Lipotec, S.A. | Pharmaceutical and cosmetic compositions which are used to prevent and treat cell ageing through the sequestration of reactive carbonyl species |
WO2005048968A1 (en) * | 2003-11-17 | 2005-06-02 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
EP1640041A2 (en) * | 2004-09-24 | 2006-03-29 | Henkel Kommanditgesellschaft auf Aktien | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin |
WO2006101855A2 (en) * | 2005-03-16 | 2006-09-28 | Procyte Corporation | Methods and compositions for preventing and treating aging or photodamaged skin |
US20110003760A1 (en) * | 2005-10-03 | 2011-01-06 | Fancl Corporation | Abnormal protein removing method |
WO2012065782A3 (en) * | 2010-11-15 | 2012-07-26 | Gelita Ag | Collagen hydrolysate used to improve the health of human skin, hair and/or nails |
US8466109B2 (en) * | 1998-10-05 | 2013-06-18 | Laboratoires Expanscience | Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
US20140335137A1 (en) * | 2011-04-29 | 2014-11-13 | Barbara F. Hayes | Topical DNA Repair Composition |
-
1992
- 1992-12-30 DE DE19924244418 patent/DE4244418A1/en not_active Withdrawn
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0781779A3 (en) * | 1995-12-27 | 1999-04-07 | Miyagi Kagaku Kogyo Kabushiki Kaisha | Nonantigenic stabilizer and physiologically active substance |
US8466109B2 (en) * | 1998-10-05 | 2013-06-18 | Laboratoires Expanscience | Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
EP1054677A4 (en) * | 1998-11-19 | 2005-07-27 | Mrs Llc | Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
EP1054677A1 (en) * | 1998-11-19 | 2000-11-29 | Mrs, Llc | Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides |
WO2001043701A2 (en) * | 1999-12-17 | 2001-06-21 | Sederma | Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide |
FR2802413A1 (en) * | 1999-12-17 | 2001-06-22 | Sederma Sa | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING THE N-PALMYTOYL-GLY-HYS-LYS TRIPEPTIDE FOR ELIMINATING, REDUCING OR PREVENTING THE APPEARANCE OF WRINKLES, WHEREVER THE LOCATION AND THE CAUSE |
WO2001043701A3 (en) * | 1999-12-17 | 2002-02-28 | Sederma Sa | Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide |
FR2827170A1 (en) * | 2001-07-13 | 2003-01-17 | Soc Extraction Principes Actif | Promoting cellular adhesion, especially for treating skin aging symptoms and improving skin appearance, using peptide having monomeric, dimeric or trimeric glycyl-prolyl-glutaminyl sequence |
WO2003007905A3 (en) * | 2001-07-13 | 2003-11-06 | Soc Extraction Principes Actif | Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
US7211269B2 (en) | 2001-07-13 | 2007-05-01 | Societe D' Extraction De Principes Actifs S.A. | Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
WO2003028693A1 (en) * | 2001-10-01 | 2003-04-10 | Hive Of Beauty (Europe) Bvba | Skin treatment compositions |
EP1297821A1 (en) * | 2001-10-01 | 2003-04-02 | Hive of Beauty (Europe) BVBA | Skin treatment compositions |
WO2004014413A1 (en) * | 2002-07-31 | 2004-02-19 | Procyte Corporation | Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
ES2228244A1 (en) * | 2003-04-01 | 2005-04-01 | Lipotec, S.A. | Pharmaceutical and cosmetic compositions which are used to prevent and treat cell ageing through the sequestration of reactive carbonyl species |
ES2228245A1 (en) * | 2003-04-01 | 2005-04-01 | Lipotec, S.A. | Composition for the prevention and treatment of cellulitis |
WO2004087191A1 (en) * | 2003-04-01 | 2004-10-14 | Lipotec, S.A. | Composition for the prevention and treatment of cellulitis |
WO2004087192A1 (en) * | 2003-04-01 | 2004-10-14 | Lipotec, S.A. | Pharmaceutical and cosmetic compositions which are used to prevent and treat cell ageing through the sequestration of reactive carbonyl species |
WO2005048968A1 (en) * | 2003-11-17 | 2005-06-02 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
US6974799B2 (en) | 2003-11-17 | 2005-12-13 | Sederma S.A.S. | Compositions containing mixtures of tetrapeptides and tripeptides |
EP1640041A2 (en) * | 2004-09-24 | 2006-03-29 | Henkel Kommanditgesellschaft auf Aktien | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin |
EP1640041A3 (en) * | 2004-09-24 | 2006-05-24 | Henkel Kommanditgesellschaft auf Aktien | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin |
WO2006101855A2 (en) * | 2005-03-16 | 2006-09-28 | Procyte Corporation | Methods and compositions for preventing and treating aging or photodamaged skin |
US7384916B2 (en) | 2005-03-16 | 2008-06-10 | Procyte Corporation | Methods and compositions for preventing and treating aging or photodamaged skin |
WO2006101855A3 (en) * | 2005-03-16 | 2006-11-02 | Procyte Corp | Methods and compositions for preventing and treating aging or photodamaged skin |
US20110003760A1 (en) * | 2005-10-03 | 2011-01-06 | Fancl Corporation | Abnormal protein removing method |
WO2012065782A3 (en) * | 2010-11-15 | 2012-07-26 | Gelita Ag | Collagen hydrolysate used to improve the health of human skin, hair and/or nails |
US9072724B2 (en) | 2010-11-15 | 2015-07-07 | Gelita Ag | Collagen hydrolysate for use to improve the health of human skin, hair and/or nails |
US20140335137A1 (en) * | 2011-04-29 | 2014-11-13 | Barbara F. Hayes | Topical DNA Repair Composition |
US9333159B2 (en) * | 2011-04-29 | 2016-05-10 | Photomedex, Inc. | Topical DNA repair composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4244418A1 (en) | Cosmetic and pharmaceutical compsn. contg. specific tri:peptide(s) - is prepd. by controlled hydrolysis of collagen, etc., for stimulating cell respiration or collagen synthesis, etc. | |
DE4244415A1 (en) | Peptide prepn contg e g, tri:peptide(s) Gly-His-Lys and/or Gly-Asp-Ser | |
DE60030766T2 (en) | USE OF AN EXTRACT OF THE GENUS VACCINIUM AS ANTI-GLYCATION AGENCY | |
US7887858B2 (en) | Cosmetic composition containing an amber extract | |
EP0949902A2 (en) | Cosmetic preparation with a peptide addition | |
KR102085559B1 (en) | Tremella fuciformis extraxt, preparation method thereof and Use the same | |
DE102004045187A1 (en) | Agent capable of inducing the transfer of inactive TGFb latent into active TGFb | |
DE60035059T2 (en) | MEDIUM TO IMPROVE SKIN TEXTURE | |
KR20180115674A (en) | Synergistic extracts of Palmaria palmata and jasmine, compositions comprising them and uses thereof | |
DE102010061237A1 (en) | Extract of the plant Ravenala madgascariensis and use as a cosmetic hydrating agent | |
EP1726296B1 (en) | Cosmetic or therapeutic combination preparation comprising theanine | |
DE4202645A1 (en) | HAIR NUTRIENTS AND ITS PRODUCTION | |
EP0220453A2 (en) | Use of extracts of plant pollen in the manufacture of pharmaceutical preparations which reduce the growth of tumour cells, and process for preparing the same | |
DE2723908A1 (en) | PHARMACEUTICAL AND COSMETIC PREPARATIONS ON THE BASIS OF ELASTIN | |
US6890566B2 (en) | Composition and method to whiten and exfoliate skin | |
DE102009012271A1 (en) | Use of a Brassocattleya marcella Koss orchid extract as an active ingredient to prevent or delay the onset of signs of aging | |
JP2002284632A (en) | Extinction substance for superoxide anion extracted from sake lees as effective component | |
JP3522609B2 (en) | Hyaluronic acid production promoter and skin external preparation containing the same | |
CN110613678B (en) | Skin conditioner and essence for removing red blood streak and preparation method | |
JPH11158054A (en) | Skin lotion | |
JP3413220B2 (en) | Skin roughness improver | |
DE19624476C2 (en) | Water soluble organ extracts with improved biochemical efficiency, process for their preparation and their use | |
EP0040604B1 (en) | Cosmetic preparation | |
DE60114940T2 (en) | Use of an Iridacea extract in a composition for the stimulation of the immune defense | |
DE1667907C2 (en) | Process for the production of mucopolysaccharides from beef or sheep fetus and hair care products containing the mucopolysaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8110 | Request for examination paragraph 44 | ||
8125 | Change of the main classification |
Ipc: A61K 38/02 |
|
8130 | Withdrawal |